Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
33%(1 trials)

Phase Distribution

Ph not_applicable
2
67%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution2 total trials
N/ANon-phased studies
2(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Completed(3)

Detailed Status

Completed3

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A2 (100.0%)

Trials by Status

completed3100%

Recent Activity

0 active trials
Showing 3 of 3
completednot_applicable

Exposure of Taxi Drivers to Ultrafine Particles and Black Carbon Within Their Vehicles

NCT03839537
completednot_applicable

COPD Assessment and Management Bundle Versus Usual Care

NCT01833026
completed

Cough in Reduced True Vocal Fold Mobility

NCT02407301

Clinical Trials (3)

Showing 3 of 3 trials
NCT03839537Not Applicable

Exposure of Taxi Drivers to Ultrafine Particles and Black Carbon Within Their Vehicles

Completed
NCT01833026Not Applicable

COPD Assessment and Management Bundle Versus Usual Care

Completed
NCT02407301

Cough in Reduced True Vocal Fold Mobility

Completed

All 3 trials loaded

Drug Details

Intervention Type
DIAGNOSTIC TEST
Total Trials
3